| Scorpions® is a homogeneous or closed-tube platform for PCR analysis. It is ideal for all diagnostic applications which require rapid and reliable PCR detection such as viral load testing, RNA profiling, pharmacogenomics and environmental analysis. Scorpions is a class leading technology with significant technical benefits over competing technologies. Product development programmes utilising DxS' experience helps companies expedite the launch of next generation molecular diagnostics. Significantly Scorpions also enjoys a strong independent Intellectual Property position and is available for license from DxS Ltd. - Sensitivity - the limit of detection is a few molecules of target nucleic acid.
- Specificity - both the Scorpion primer region and probe region can be made sequence specific. This gives unparalleled discrimination allowing the detection of single nucleotide changes even in admixtures where the alternative sequence is in vast excess.
- Speed - Scorpions signal generation is widely recognised as the fastest in its class. This means that the technology can support very rapid PCR allowing detection in less than ten minutes.
- Difficult Sequences - the intra-molecular signal generation mechanism means that Scorpions are particularly good at detecting targets in regions of high G+C content or secondary structure.
- Scorpions already has worldwide patent coverage with granted patents in USA and Europe and protection in Japan. This is in contrast to other detection systems which are not currently protected in Europe.
- Scorpions is owned by DxS Ltd. As an independent biotechnology company we are able to tailor a licensing agreement to meet the needs of our clients and if required can provide support ranging from technology transfer all the way through to diagnostic design and development.
| | 
|
| |